Submitted for Publication: June 25, 2011; final revision received September 21, 2011; accepted November 16, 2011.
Author Contributions: Drs Statham, de Alarcon, and Tabangin had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: McCarty Statham, de Alarcon, Germann, and Rutter. Acquisition of data: McCarty Statham. Analysis and interpretation of data: McCarty Statham, de Alarcon, Tabangin, Cohen, and Rutter. Drafting of the manuscript: McCarty Statham, de Alarcon, Germann, Cohen, and Rutter. Critical revision of the manuscript for important intellectual content: de Alarcon, Tabangin, and Rutter. Statistical analysis: de Alarcon and Tabangin. Administrative, technical, and material support: McCarty Statham, de Alarcon, and Germann. Study supervision: de Alarcon and Rutter.
Financial Disclosure: Dr Rutter has the following relationships to disclose: Acclarent (scientific advisory board), Gyrus/Olympus (consultant), Boston Medical Products (consultant), Hood Laboratories (consultant), Bryan Medical (consultant), and Karl Storz (consultant).
Previous Presentation: This study was presented at the annual meeting of the American Society of Pediatric Otolaryngology; May 2, 2010; Las Vegas, Nevada.
Additional Contributions: Beverly Connelly, MD, director of the infection control program, assisted in the development of our antibiotic protocol.